Drugs / Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid
Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04288323 Background | Apr 2018 → Dec 2025 | carcinoma of liver and intrahepatic biliary tract, cirrhosis of liver | University of California, San Diego | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04288323 ↗ |